INSTITUT CURIE
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1909-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.curie.fr
First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years
- First Posted Date
- 2017-01-05
- Last Posted Date
- 2024-01-29
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 45
- Registration Number
- NCT03011528
- Locations
- 🇫🇷
Nantes Chu, Nantes, France
🇫🇷Bordeaux Chu, Bordeaux, France
🇫🇷Chr Felix Guyon, La Réunion, Saint Denis, France
Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)
- First Posted Date
- 2016-08-23
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 800
- Registration Number
- NCT02875652
- Locations
- 🇫🇷
Institut Curie, Paris, France
Endoresection of the Tumor Scar or Transpupillary Thermotherapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)
- Conditions
- Interventions
- First Posted Date
- 2016-08-22
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 87
- Registration Number
- NCT02874040
- Locations
- 🇫🇷
Institut Curie, Paris, France
Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)
- First Posted Date
- 2016-08-17
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 185
- Registration Number
- NCT02870907
- Locations
- 🇫🇷
Chr Felix Guyon, Saint-Denis, La Réunion, France
🇫🇷Hopital Nord Chu Amiens, Amiens, France
🇫🇷Chu Angers, Angers, France
Conservative Treatments of Retinoblastoma
- Conditions
- Interventions
- First Posted Date
- 2016-08-15
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 133
- Registration Number
- NCT02866136
- Locations
- 🇫🇷
Institut Curie, Paris, France
Analysis of Circulating Tumor Markers in the Blood (ALCINA)
- Conditions
- Interventions
- First Posted Date
- 2016-08-15
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 682
- Registration Number
- NCT02866149
- Locations
- 🇫🇷
Institut Curie (Paris hospital), Paris, France
🇫🇷Centre Georges François Leclerc, Dijon, France
🇫🇷Institut du Cancer de Montpellier, Montpellier, France
Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification
- First Posted Date
- 2016-08-12
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 560
- Registration Number
- NCT02864563
- Locations
- 🇫🇷
CHU MORVAN Brest, Brest, France
🇫🇷Hôpital Nord Amiens, Amiens, France
🇫🇷Chu Angers, Angers, France
FSH-R : Diagnostic Application for Localized Tumors in Cancerology
- First Posted Date
- 2016-08-09
- Last Posted Date
- 2023-08-24
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 95
- Registration Number
- NCT02860481
- Locations
- 🇫🇷
Centre René Huguenin, Saint Cloud, France
🇫🇷Institut Curie, Paris, France
Prospective Observational Study to Investigate the Added Value of the Health Related Quality of Life and Patient Reported Symptoms in the Identification of the Recommended Phase II Dose in Phase I Trials of Molecularly Targeted Therapies.
- Conditions
- First Posted Date
- 2016-08-05
- Last Posted Date
- 2016-08-05
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 250
- Registration Number
- NCT02857699
- Locations
- 🇫🇷
Centre Georges Francois Leclerc, Dijon, France
🇫🇷Institut Curie, Paris, France
🇫🇷Centre Claudius Regaud, Toulouse, France
Impact of a Booklet-Question List on Cancer Patients or Their Families Seeking Prognostic Information During a Palliative Care Consultation
- First Posted Date
- 2016-08-03
- Last Posted Date
- 2016-08-03
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 121
- Registration Number
- NCT02854293
- Locations
- 🇫🇷
Centre Alexis Vautrin, Nancy, France
🇫🇷Léon Berard, Lyon, France
🇫🇷Hopital René Huguenin, Saint Cloud, France